What is Kleresca®?
Kleresca® is a breakthrough BioPhotonic treatment that significantly and comfortably improves acne vulgaris with high safety. It is offered in professional dermatology clinics.
Kleresca® harnesses the power of BioPhotonics to treat your acne and stimulate the tissue’s own repair systems. The treatment uses a high intensity in-clinic light device together with a photoconverter gel to kill bacteria in the skin and initiate healing.
Kleresca® is administered twice a week for six weeks. The treatment offers you a comfortable experience. A nurse or practitioner will apply a photoconverter gel that is illuminated under a multi-wavelength LED light for nine minutes. That is it.
What is BioPhotonics
How it works
While you may feel a warming sensation on your skin, most people find the treatment pleasant and comfortable.After nine minutes under the light, the gel is removed. Your complexion may experience redness after the treatment.
Who is it for?
Kleresca® is an effective treatment for all kinds of acne vulgaris, even severe cases. To start the treatment, you should schedule a consultation at a Kleresca® clinic. Your dermatologist or clinician will determine whether treatment with Kleresca® is right for you.
What to expect
You should see noticeable improvements to your skin as the deeper layers respond and skin repairing occurs during the six-week treatment course.
For at least six weeks after your treatment, you can expect to see additional improvements to your complexion. Results have been seen to have a long-lasting effect.
Read in the safety information below about the most common side effects.
In clinical trials, Kleresca® showed high efficacy on people with moderate to severe acne. Nine out of 10 people saw an improvement to their skin*, whereas every third person achieved clear or almost clear skin.Results have been seen to have long-lasting effect. In an extended clinical trial, 92% of the people who had previously achieved an improvement of two grades or more on the Investigators’ Global Assessment (IGA) scale for acne severity went on to maintain this improvement. None of the people treated returned to their original acne severity.
*Nine out of 10 persons saw an improvement of at least 1 IGA grade or more
The Kleresca® treatment takes place on your skin and is not absorbed or metabolised, making it a well-tolerated treatment option for acne.
In clinical trials, Kleresca® showed high safety with no serious adverse events, and the treatment itself was considered to be a pleasant and comfortable experience. Side effects seen in those treated include, redness, hyperpigmentation (bronzing of an area of the skin) and slight discoloration of hair. All side effects were transient and did not require any intervention by the clinic.